Your browser doesn't support javascript.
loading
Misoprostol for intrauterine fetal death.
Gómez Ponce de León, R; Wing, D; Fiala, C.
Afiliação
  • Gómez Ponce de León R; Ipas and School of Public Health, UNC at Chapel Hill, Chapel Hill, NC 27510, USA. gomezr@ipas.org
Int J Gynaecol Obstet ; 99 Suppl 2: S190-3, 2007 Dec.
Article em En | MEDLINE | ID: mdl-17961568
ABSTRACT
The frequency of intrauterine fetal death (IUFD) with retained fetus varies, but is estimated to occur in 1% of all pregnancies. The vast majority of women will spontaneously labor and deliver within three weeks of the intrauterine death. The complexity in medical management increases significantly when the cervix is unripe or unfavorable, or when the woman develops disseminated intravascular coagulation. Misoprostol regimens for the induction of labor for second and third trimester IUFDs, range from 50 to 400 microg every 3 to 12 h, and are all clinically effective. Nevertheless, the current scientific evidence supports vaginal misoprostol dosages, which are adjusted to gestational age between 13-17 weeks, 200 microg 6-hourly; between 18-26 weeks, 100 microg 6-hourly; and more than 27 weeks, 25-50 microg 4-hourly. In women with a previous cesarean, lower doses should be used and doubling of doses should not occur. Clinical monitoring should continue after delivery or expulsion because of the risk of postpartum atony and/or placenta retention.
Assuntos
Buscar no Google
Base de dados: MEDLINE Assunto principal: Abortivos não Esteroides / Misoprostol / Aborto Retido / Morte Fetal Limite: Female / Humans / Pregnancy Idioma: En Ano de publicação: 2007 Tipo de documento: Article
Buscar no Google
Base de dados: MEDLINE Assunto principal: Abortivos não Esteroides / Misoprostol / Aborto Retido / Morte Fetal Limite: Female / Humans / Pregnancy Idioma: En Ano de publicação: 2007 Tipo de documento: Article